MACK
Lazard Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,830
| Closed | -$41K | – | 2483 |
|
|
2024
Q1 | $41K | Hold |
2,830
| – | – | ﹤0.01% | 1761 |
|
|
2023
Q4 | $37K | Sell |
2,830
-293
| -9% | -$3.83K | ﹤0.01% | 1975 |
|
|
2023
Q3 | $38K | Hold |
3,123
| – | – | ﹤0.01% | 1935 |
|
|
2023
Q2 | $38K | Sell |
3,123
-1,828
| -37% | -$22.2K | ﹤0.01% | 1920 |
|
|
2023
Q1 | $60K | Buy |
+4,951
| New | +$60K | ﹤0.01% | 1739 |
|
|
2016
Q3 | – | Sell |
-930
| Closed | -$5K | – | 1084 |
|
|
2016
Q2 | $5K | Sell |
930
-83,370
| -99% | -$448K | ﹤0.01% | 1000 |
|
|
2016
Q1 | $705K | Buy |
84,300
+81,525
| +2,938% | +$682K | ﹤0.01% | 698 |
|
|
2015
Q4 | $21K | Buy |
+2,775
| New | +$21K | ﹤0.01% | 974 |
|
|
2015
Q3 | – | Sell |
-6,928
| Closed | -$85K | – | 1200 |
|
|
2015
Q2 | $85K | Buy |
+6,928
| New | +$85K | ﹤0.01% | 930 |
|